Boston Scientific(FRA) BSX

Market Cap€58.16B

Since IPON/A

5 YearN/A

1 YearN/A

1 MonthN/A

€41.53

-0.90%

-0.38Today

Boston Scientific Financials at a Glance

Market Cap

€58.16B

Revenue (TTM)

$20.98B

Net Income (TTM)

$3.66B

EPS (TTM)

€2.11

P/E Ratio

18.99

Dividend

€0.00

Beta (Volatility)

-0.01 (Low)

Dividend

€0.00

Beta (Volatility)

-0.01 (Low)

Price

€41.53

Volume

Open

€41.53

Price

€41.53

Volume

Open

€41.53

Previous Close

€41.90

Daily Range

€41.53 - €41.53

52-Week Range

€36.59 - €93.00

Estimated Earnings Date

Oct 28, 2026

Dividend

€0.00

Beta (Volatility)

-0.01 (Low)

Price

€41.53

Volume

Open

€41.53

Previous Close

€41.90

Daily Range

€41.53 - €41.53

52-Week Range

€36.59 - €93.00

Estimated Earnings Date

Oct 28, 2026

BSX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Boston Scientific

Boston Scientific Corporation is a global leader in designing, manufacturing, and marketing advanced medical devices. Founded in 1979 and headquartered in Marlborough, Massachusetts, the company serves a wide range of interventional medical specialties worldwide.

Products and Services

Advanced medical devices for various interventional specialties
Technologies for diagnosing and treating gastrointestinal and cardiovascular conditions
Neuromodulation solutions for chronic pain management

Growth Outlook

Revenue of €5.45 billion in Q2 2026, showing strong demand
Net income of €903.8 million in Q2 2026, reflecting profitability
TTM gross profit margin of 71.16%, indicating operational efficiency

Financial Highlights

Operating income of €1.25 billion in Q2 2026, showcasing robust performance
Net profit margin of 16.59% in Q2 2026, demonstrating effective cost management
TTM return on equity of 14.90%, highlighting strong shareholder value

AI Generated • Aug 13, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

59,000

CEO

Michael F. Mahoney, MBA

Website

www.bostonscientific.com

Headquarters

Marlborough, MA 01752-1234, US

BSX Financials

Key Financial Metrics (TTM)

Gross Margin

71.16%

Operating Margin

21.46%

Net Income Margin

17.47%

Return on Equity

14.90%

Return on Capital

10.83%

Return on Assets

8.11%

Earnings Yield

5.27%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

€58.16B

Shares Outstanding

1.45B

Volume

Avg. Volume

436.758

Financials (TTM)

Gross Profit

$14.44B

Operating Income

$4.55B

EBITDA

$4.83B

Operating Cash Flow

$4.53B

Capital Expenditure

-$2.70B

Free Cash Flow

$1.82B

Cash & ST Invst.

$648.57M

Total Debt

$12.62B

Boston Scientific Performance Analysis

Boston Scientific annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	USD 12,066,898,115	20.0%
2023	2023-12-31	USD 13,171,579,395	9.2%
2024	2024-12-31	USD 15,482,243,795	17.5%
2025	2025-12-31	USD 17,786,985,817	14.9%

Boston Scientific sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-09-30	0.1%
Q4	2025-12-31	4.4%
Q1	2026-03-31	-1.9%
Q2	2026-06-30	5.1%

Boston Scientific annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	USD 0.42	-27.0%
2023	2023-12-31	USD 0.99	133.9%
2024	2024-12-31	USD 1.15	16.2%
2025	2025-12-31	USD 1.72	49.0%

Boston Scientific sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-09-30	-5.7%
Q4	2025-12-31	-10.0%
Q1	2026-03-31	100.0%
Q2	2026-06-30	-32.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$5.45B

+7.6%

Gross Profit

$3.85B

+12.5%

Gross Margin

70.71%

N/A

Market Cap

€58.16B

N/A

Market Cap/Employee

€985.84K

N/A

Employees

59,000

N/A

Net Income

$903.80M

+13.4%

EBITDA

$1.25B

-8.8%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

$648.57M

+21.5%

Total Debt

$12.62B

+5.0%

Accounts Receivable

$3.05B

+8.3%

Inventory

$0.00

-100.0%

Long Term Debt

$10.92B

-5.5%

Short Term Debt

$1.71B

+256.0%

Return on Assets

8.11%

N/A

Return on Invested Capital

11.62%

N/A

Free Cash Flow

-$451.00M

-141.1%

Operating Cash Flow

$1.47B

+14.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,684.24-0.00%

^DJIDJI

^DJIDJI$53,254.61-0.01%

^IXICNASDAQ

^IXICNASDAQ$26,319.55-0.00%

BTCBitcoin

BTCBitcoin$78,890.00-0.00%

SPCXSPCX

SPCXSPCX$142.81+0.01%

AAPLAAPL

AAPLAAPL$315.25-0.01%

AMZNAMZN

AMZNAMZN$258.45-0.03%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

WETOWetour Robotics

WETOWetour Robotics$5.48-0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$71.92+0.00%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$44.67+0.02%

INTCIntel

INTCIntel$89.51+0.00%

NVDANvidia

NVDANvidia$220.78+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.97+0.11%

TLTiShares Trust - iShares 20+ Year Treasury Bond ETF

TLTiShares Trust - iShares 20+ Year Treasury Bond ETF$82.52-0.00%

Questions About BSX

What is the current price of Boston Scientific?

Boston Scientific is trading at €41.53 per share.

What is the 52-week range for Boston Scientific?

Over the past 52 weeks, Boston Scientific has traded between €36.59 and €93.00.

How much debt does Boston Scientific have?

As of the most recent reporting period, Boston Scientific reported total debt of $11.04B.

How much cash does Boston Scientific have on hand?

Boston Scientific reported $566.78M in cash and cash equivalents in its most recent financial results.

What is Boston Scientific’s dividend yield?

Boston Scientific does not currently have a dividend yield.

Boston Scientific(FRA) BSX

Boston Scientific Financials at a Glance

BSX News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Boston Scientific

BSX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Boston Scientific Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BSX

What is the current price of Boston Scientific?

What is the 52-week range for Boston Scientific?

How much debt does Boston Scientific have?

How much cash does Boston Scientific have on hand?

What is Boston Scientific’s dividend yield?

Premium Investing Services